Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Bombardieri

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 3, 2007
Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumorMaura Massimino, Lorenza Gandola, Paola Collini, et al.
Plos One|May 24, 2018
[18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancerIsabella Raccagni, Sara Belloli, Silvia Valtorta, et al.
Hepatology (Baltimore, Md.)|August 23, 2012
Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 studyVincenzo Mazzaferro, Carlo Sposito, Sherrie Bhoori, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2010
131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imagingEmilio Bombardieri, Francesco Giammarile, Cumali Aktolun, et al.
Anticancer Research|August 21, 2003
Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetateAntonia Martinetti, Nicoletta Zilembo, Leonardo Ferrari, et al.
Clinical Nuclear Medicine|June 24, 2003
Somatostatin receptor scintigraphy for bronchial carcinoid follow-upStefano Fanti, Mohsen Farsad, Giuseppe Battista, et al.
Oncology|January 19, 2013
Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?Chiara Bampo, Alessandra Alessi, Simona Fantini, et al.
Journal of Immunology Research|September 12, 2022
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or VaccinationFrancesca Dapporto, Serena Marchi, Margherita Leonardi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2015
¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot studyFlavio Crippa, Roberto Agresti, Marco Sandri, et al.
Breast (Edinburgh, Scotland)|February 4, 2014
Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-upRoberto Agresti, Flavio Crippa, Marco Sandri, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Radiation Oncology, Biology, Physics|July 3, 2007
Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumorMaura Massimino, Lorenza Gandola, Paola Collini, et al.
Plos One|May 24, 2018
[18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancerIsabella Raccagni, Sara Belloli, Silvia Valtorta, et al.
Hepatology (Baltimore, Md.)|August 23, 2012
Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 studyVincenzo Mazzaferro, Carlo Sposito, Sherrie Bhoori, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2010
131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imagingEmilio Bombardieri, Francesco Giammarile, Cumali Aktolun, et al.
Anticancer Research|August 21, 2003
Bone turnover markers and insulin-like growth factor components in metastatic breast cancer: results from a randomised trial of exemestane vs megestrol acetateAntonia Martinetti, Nicoletta Zilembo, Leonardo Ferrari, et al.
Clinical Nuclear Medicine|June 24, 2003
Somatostatin receptor scintigraphy for bronchial carcinoid follow-upStefano Fanti, Mohsen Farsad, Giuseppe Battista, et al.
Oncology|January 19, 2013
Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?Chiara Bampo, Alessandra Alessi, Simona Fantini, et al.
Journal of Immunology Research|September 12, 2022
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or VaccinationFrancesca Dapporto, Serena Marchi, Margherita Leonardi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2015
¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot studyFlavio Crippa, Roberto Agresti, Marco Sandri, et al.
Breast (Edinburgh, Scotland)|February 4, 2014
Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-upRoberto Agresti, Flavio Crippa, Marco Sandri, et al.
Pageof 9